Vident Advisory’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.6M Buy
152,477
+831
+0.5% +$186K 0.28% 69
2025
Q4
$26M Buy
151,646
+29,231
+24% +$4.55M 0.24% 90
2025
Q3
$16.4M Buy
122,415
+74,550
+156% +$7.89M 0.16% 125
2025
Q2
$4.66M Buy
47,865
+6,155
+15% +$488K 0.05% 296
2025
Q1
$3.03M Buy
41,710
+5,806
+16% +$457K 0.04% 349
2024
Q4
$2.59M Buy
35,904
+2,374
+7% +$180K 0.05% 357
2024
Q3
$2.74M Sell
33,530
-54,660
-62% -$4.75M 0.07% 310
2024
Q2
$9.39M Sell
88,190
-2,910
-3% -$279K 0.26% 81
2024
Q1
$8.85M Sell
91,100
-232,170
-72% -$20.4M 0.18% 168
2023
Q4
$25.3M Buy
323,270
+15,560
+5% +$1.06M 0.64% 18
2023
Q3
$19.3M Buy
+307,710
New +$20.2M 0.6% 25

Other funds holding LRCX

Vident Advisory's LRCX Position: Q1 2026 in Review

Vident Advisory increased its Lam Research (LRCX) stake by 0.55% in Q1 2026, buying an estimated $186K and bringing the position to 152,477 shares worth $32.6M. The position accounts for 0.28% of the portfolio, ranked #69.

Vident Advisory first reported a position in LRCX in Q3 2023 and has held it in 11 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Vident Advisory held 152,477 shares of Lam Research worth $32.6M as of Q1 2026.
  • Vident Advisory bought 831 Lam Research shares in Q1 2026, an estimated $186K.
  • Lam Research made up 0.28% of Vident Advisory's portfolio in Q1 2026, its #69 holding.
  • Vident Advisory first reported a position in Lam Research in Q3 2023 and has held it in 11 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.